TokenPost topic

vTv Therapeutics

1 TokenPost story is tagged vTv Therapeutics. The newest appear first.

Latest vTv Therapeutics stories

• vTv Therapeutics Posts a $0.94 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate

  Cash and cash equivalents were $77.2 million on Sept. 30, 2026, compared with $88.9 million on Dec. 31, 2025.

  Nov 7, 2026, 9:32 AM EST · Business